LUPIN
Lupin Limited
Healthcare
Share price
₹2,202
Market cap
₹1.0L Cr
1Y return
▲ 13%
An innovation-led pharmaceutical company headquartered in Mumbai, Lupin develops and commercializes a broad range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The company operates as a transnational enterprise, serving customers across more than 100 markets including the United States, India, South Africa, Asia Pacific, Latin America, Europe, and the Middle East regions.
Investors holding Lupin Limited
Latest move
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held a 1.45 percent stake in Lupin Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete sale or a reduction in its holding to below the 1 percent reporting requirement.
Sign in to read more
Whales made 6 more moves in Lupin Limited
Sign in to see who is buying and selling.
Sign in to find out